Make the best use of Researched information from 700+ peer reviewed, Open Access Journals operated by 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
Conference Series LLC LTD in the field of Infectious diseases provides a platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc. The Conference Involves Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists and Health Care Professionals.
Conference Series is conducting conferences related Infectious diseases every year in the areas like Bacteriology , Retroviruses, Flu, HIV and Epidemiology
Market Analysis
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. The overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.
Conference Series LLC LTD
Conference Series LLC LTD, the Global leader in organizing 1000+ Global Events and Expos across the Globe with the seamless support from 700+ Open Access Journals and 1000+ Societies. The aim of the conferences is to host presentations from renowned experts across the World to harness the new collaborations in Immunology, Microbiology and Biomedical Sciences. Therefore, Researchers in the relevant field can present their research to discuss the new results. Emerging sessions includes, Young Research Forum and Poster sessions offering chance to young participants to develop their career in all the orientations. Potential presentations from Investigators at every career stage reporting their latest research findings in oral and poster sessions. This leads to dissemination of current research across the World.
Conference Series LLC LTD are planned as group of events composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. These events are major avenues for the young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe. Innovative young researchers receive Young Scientist Awards for their contributions.
Scope& Importance
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.
The infectious disease specialist is directly involved in the diagnosis and treatment of the most severe or rare affections. However, he influences in a more general fashion the management of anti-infectious treatments by directing the treatment plan and helping to choose the proper antibiotics. Resistant organisms of special epidemiologic importance in health care settings include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and gram-negative rods that produce extended spectrum β-lactamases (ESBLs). Clostridium difficile, which is usually not included in discussions of multidrug-resistant bacteria, is also an important pathogen resistant to many antimicrobial agents. Recently, vancomycin-intermediate S. aureus (VISA) infections have been documented in several patients, and there is concern that such strains will become more prevalent. More than 3000 infectious diseases treated in the past 10 years at the Department of Medicine. Implementation of clinical practice guidelines is one of several recommendations made to improve use of antimicrobial agents. For example, many hospitals have adopted the Hospital Infection Control Practices Advisory Committee (HICPAC) guideline for appropriate use of vancomycin. Educational efforts, such as lectures dealing with appropriate use of antimicrobial agents, are still recommended, although a number of studies have demonstrated that periodic lectures often have little long-term impact on physician prescribing practices.
Major Companies Related to Infectious Diseases
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi